Juno Therapeutics

Today we welcomed Dr. Leslie S. Kean, Associate Director, Ben Towne Center for Childhood Cancer Research @seattlechildren to learn how she is working to solve the mystery of immune recognition and immune tolerance. #womeninscience

This Sunday, Feb 11th, is International Day of Women and Girls in Science. Juno is proud to support #WomeninScience! Check out @WomenScienceDay to learn more and see events happening around the world.

We were thrilled to welcome @ClaireShipman to Juno to discuss how confidence drives career development and impact.

Juno Names Cindy Elkins Chief Information Officer: businesswire.com/news/home/2018…

On behalf of our employees, we'd like to wish everyone a very happy holiday and healthy new year!

Juno Therapeutics Highlights Data and Presentations Supporting Best-in-Class Strategy for JCAR017 at ASH. Read more: businesswire.com/news/home/2017…

There's still time to stop by Booth #523 to learn more about our pipeline. #ASH17 Impt info: bit.ly/juno-cg

Today we announced updated results from the TRANSCEND study of JCAR017 in non-Hodgkin lymphoma businesswire.com/news/home/2017… Impt. Info: bit.ly/juno-cg

Juno highlights key translational insights with JCAR017 in patients with DLBCL. Read more here: businesswire.com/news/home/2017…

Curious about Juno's #ASH17 presentations? Find out our schedule here: bit.ly/JunoTheraASH20… Impt. Info: bit.ly/juno-cg

Juno will have 9 presentations at #ASH17. Learn more at bit.ly/JunoTheraASH20… Impt. Info: bit.ly/juno-cg

Juno signs agreements with Eli Lilly, OncoTracker and @FredHutch to advance multiple myeloma program: businesswire.com/news/home/2017…

We're one week out from #ASH17 - Take a look at the schedule of our presentations and join us in Atlanta: bit.ly/JunoTheraASH20… Impt. Info: bit.ly/juno-cg

Juno appoints Ann L. Lee as EVP of Technical Operations and Patrick Y. Yang as EVP, Senior Advisor to the CEO businesswire.com/news/home/2017…

#tbt Remembering the September opening of our new #Seattle #HQ #400Dexter #changingmedicineforgood #CAR_T Impt. info: bit.ly/juno-cg bit.ly/2hjps2L

Today @JunoThera releases 3Q17 results and update on new data from JCAR017. Read more here: businesswire.com/news/home/2017…

Juno to highlight new advances in CD19- and BCMA-targeted CAR T therapy at #ASH17: businesswire.com/news/home/2017…

Rain didn’t stop us last night from supporting @LLSusa @LTN_WA for #BloodCancer #research. @LLSwaak

Congratulations to @GileadSciences & @KitePharma. Every approved #CAR_T is a positive step in the fight against cancer.

Dr. Rebecca Gardner of @seattlechildren discusses CAR T findings in children with r/r CD19+ ALL. Impt info: bit.ly/Juno-cg